Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Ann Agric Environ Med ; 31(2): 193-197, 2024 Jun 27.
Artículo en Inglés | MEDLINE | ID: mdl-38940102

RESUMEN

INTRODUCTION AND OBJECTIVE: Intestinal parasitoses are important causes of morbidity and mortality, especially in immunocompromised individuals. In patients with chronic renal insufficiency (CRI), the accumulation of non-excreted metabolites leads to uraemia, which induces a state of immunodeficiency, increasing the incidence of infections. The aim of the study was molecular screening for enteric protozoa in patients with chronic renal insufficiency. MATERIAL AND METHODS: A total of 53 samples were collected in January 2023 from patients undergoing dialysis at Logman Ltd. Nephrodialysis Centre in Kosice, Slovakia. Samples were examined by polymerase chain reaction (PCR) for the presence of Cryptosporidium parvum / Cryptosporidium hominis, Giardia intestinalis, Microsporidia spp., and Blastocystis sp. RESULTS: From the 53 samples, the only pathogen identified by PCR was Blastocystis sp., in 13 patients (24.5 %). Sequence analyses confirmed that the most prevalent subtype (ST) among patients was ST 3 (n=9, 69.2%), followed by ST 1 (n=3, 23.1%) and ST 2 (n=1, 7.7%). CONCLUSIONS: Molecular methods for the detection of microscopic enteric parasites are not used as a first-line diagnostic method in Slovakia. In immunocompromised patients, diarrhoea can be caused not only by a chronic disease or therapy but can also be a result of an ongoing underdiagnosed infection. Early diagnosis leads to targeted therapy and subsequent partial improvement of the quality of life. This study also shows the first insights into Blastocystis sp. subtype distribution in humans in Slovakia.


Asunto(s)
Infecciones por Blastocystis , Blastocystis , Diálisis Renal , Humanos , Eslovaquia/epidemiología , Blastocystis/genética , Blastocystis/aislamiento & purificación , Masculino , Femenino , Persona de Mediana Edad , Infecciones por Blastocystis/parasitología , Infecciones por Blastocystis/epidemiología , Infecciones por Blastocystis/diagnóstico , Anciano , Reacción en Cadena de la Polimerasa , Adulto , Insuficiencia Renal Crónica/parasitología , Heces/parasitología , Parasitosis Intestinales/epidemiología , Parasitosis Intestinales/parasitología , Parasitosis Intestinales/diagnóstico , Anciano de 80 o más Años
2.
Acta Medica (Hradec Kralove) ; 49(1): 41-5, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16696442

RESUMEN

The aim of the study was to assess the prevalence, clinical impact and importance of different risk factors of transmission of TTV infection in Slovakia using two PCR methods. Sera of 426 adult persons were examined. TTV DNA was identified by PCR using primers from N22 and untranslated region (UTR) respectively. The established prevalence of TTV tested with N22 and UTR primers according to patients groups was: acute hepatitis of unknown etiology 4 resp. 28 of 37, acute hepatitis B 3 resp. 29 of 38, chronic hepatitis B 11 resp. 41 of 44, chronic hepatitis C 10 resp. 93 of 102, hemodialysis patients 13 resp. 72 of 72, health care workers 0 resp. 27 of 33, control group 8 resp. 83 of 100. Using N22 primers, TTV infection occurred more frequently in chronic hepatitis B group compared with health care workers, if UTR primers were used the group of hemodialysis patients differed significantly from both acute hepatitis groups, health care workers and controls (p < 0.05). From possible risk factors hemodialysis and transfusion count showed notable differences. Bilirubin and aminotransferase levels did not differ between TTV positive and negative groups. No pathogenetic role of TT virus in liver injury was confirmed.


Asunto(s)
Infecciones por Virus ADN/epidemiología , Torque teno virus , Adulto , Infecciones por Virus ADN/transmisión , Femenino , Personal de Salud , Hepatitis Viral Humana/virología , Humanos , Masculino , Reacción en Cadena de la Polimerasa , Prevalencia , Diálisis Renal/efectos adversos , Factores de Riesgo , Eslovaquia/epidemiología , Reacción a la Transfusión
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA